| Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate M Gendrot, I Duflot, M Boxberger, O Delandre, P Jardot, M Le Bideau, ... International journal of infectious diseases 99, 437-440, 2020 | 98 | 2020 |
| Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation M Gendrot, J Andreani, M Boxberger, P Jardot, I Fonta, M Le Bideau, ... Travel Medicine and Infectious Disease 37, 101873, 2020 | 89 | 2020 |
| In vitro antiviral activity of doxycycline against SARS-CoV-2 M Gendrot, J Andreani, P Jardot, S Hutter, O Delandre, M Boxberger, ... Molecules 25 (21), 5064, 2020 | 86 | 2020 |
| Genetic diversity and deletion of Plasmodium falciparum histidine-rich protein 2 and 3: a threat to diagnosis of P. falciparum malaria M Gendrot, R Fawaz, J Dormoi, M Madamet, B Pradines Clinical Microbiology and Infection 25 (5), 580-585, 2019 | 80 | 2019 |
| Methylene blue inhibits replication of SARS-CoV-2 in vitro M Gendrot, J Andreani, I Duflot, M Boxberger, M Le Bideau, J Mosnier, ... International Journal of Antimicrobial Agents 56 (6), 106202, 2020 | 77 | 2020 |
| Chloroquine as a prophylactic agent against COVID-19? M Gendrot, E Javelle, A Clerc, H Savini, B Pradines International journal of antimicrobial agents 55 (6), 105980, 2020 | 48 | 2020 |
| Plasmodium ovale wallikeri and P. ovale curtisi Infections and Diagnostic Approaches to Imported Malaria, France, 2013–2018 V Joste, J Bailly, V Hubert, C Pauc, M Gendrot, E Guillochon, M Madamet, ... Emerging infectious diseases 27 (2), 372, 2021 | 27 | 2021 |
| Synthesis and antiplasmodial evaluation of 1H-1, 2, 3-triazole grafted 4-aminoquinoline-benzoxaborole hybrids and benzoxaborole analogues A Saini, S Kumar, R Raj, S Chowdhary, M Gendrot, J Mosnier, I Fonta, ... Bioorganic Chemistry 109, 104733, 2021 | 22 | 2021 |
| A Novel Hybrid of Chloroquine and Primaquine Linked by Gold (I): Multitarget and Multiphase Antiplasmodial Agent C de Souza Pereira, H Costa Quadros, DR Magalhaes Moreira, W Castro, ... ChemMedChem 16 (4), 662-678, 2021 | 21 | 2021 |
| Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor … F Foguim Tsombeng, M Gendrot, MG Robert, M Madamet, B Pradines Malaria journal 18 (1), 285, 2019 | 18 | 2019 |
| Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs … FT Foguim, H Bogreau, M Gendrot, J Mosnier, I Fonta, N Benoit, ... Malaria Journal 19, 1-9, 2020 | 16 | 2020 |
| Amide Tethered 4-Aminoquinoline-naphthalimide Hybrids: A New Class of Possible Dual Function Antiplasmodials Shalini, S Kumar, M Gendrot, I Fonta, J Mosnier, N Cele, P Awolade, ... ACS Medicinal Chemistry Letters 11 (12), 2544-2552, 2020 | 16 | 2020 |
| Absence of a high level of duplication of the plasmepsin II gene in Africa MG Robert, F Foguim Tsombeng, M Gendrot, J Mosnier, R Amalvict, ... Antimicrobial Agents and Chemotherapy 62 (11), 10.1128/aac. 00374-18, 2018 | 13 | 2018 |
| Absence of association between polymorphisms in the pfcoronin and pfk13 genes and the presence of Plasmodium falciparum parasites after treatment with artemisinin derivatives … O Delandre, SM Daffe, M Gendrot, MN Diallo, M Madamet, MB Kounta, ... International Journal of Antimicrobial Agents 56 (6), 106190, 2020 | 12 | 2020 |
| Association between Polymorphisms in the Pfmdr6 Gene and Ex Vivo Susceptibility to Quinine in Plasmodium falciparum Parasites from Dakar, Senegal M Gendrot, S Diawara, M Madamet, MB Kounta, S Briolant, KA Wade, ... Antimicrobial Agents and Chemotherapy 61 (3), 10.1128/aac. 01183-16, 2017 | 12 | 2017 |
| Baseline Ex Vivo and Molecular Responses of Plasmodium falciparum Isolates to Piperaquine before Implementation of Dihydroartemisinin-Piperaquine in Senegal MG Robert, F Foguim Tsombeng, M Gendrot, S Diawara, M Madamet, ... Antimicrobial Agents and Chemotherapy 63 (5), 10.1128/aac. 02445-18, 2019 | 11 | 2019 |
| Nucleoside-lipid-based nanocarriers for methylene blue delivery: potential application as anti-malarial drug K Kowouvi, B Alies, M Gendrot, A Gaubert, G Vacher, K Gaudin, J Mosnier, ... RSC Advances 9 (33), 18844-18852, 2019 | 10 | 2019 |
| Analysis of trapped mosquito excreta as a noninvasive method to reveal biodiversity and arbovirus circulation G L'Ambert, M Gendrot, S Briolant, A Nguyen, S Pages, L Bosio, V Palomo, ... Molecular Ecology Resources 23 (2), 410-423, 2023 | 9 | 2023 |
| Cytotoxic and Anti-Plasmodial Activities of Stephania dielsiana YC Wu Extracts and the Isolated Compounds J Knockleby, B Pradines, M Gendrot, J Mosnier, TT Nguyen, TT Trinh, ... Molecules 25 (16), 3755, 2020 | 9 | 2020 |
| Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants O Delandre, M Gendrot, P Jardot, M Le Bideau, M Boxberger, C Boschi, ... Pharmaceuticals 15 (4), 445, 2022 | 8 | 2022 |
Bruno PradinesInstitut de recherche biomédicale des armées, IHU Méditerranée Infection, MarseilleVerified email at intradef.gouv.fr
